Some people may do well with brief interventions, for example, while others may need more intense behavioral treatments, medication, or both, says Leggio
GLP-1 receptor agonists are currently approved as a treatment for people with type 2 diabetes and /or obesity, but researchers are looking into the potential use of GLP-1 receptor agonists for treating MASLD and MASH because of the link between these conditions, diabetes and obesity
Metabolic Dysfunction as a Driver of Colorectal Cancer Risk Over the past decade, the conceptual framework of colorectal cancer prevention has expanded to include metabolic health as a central determinant of cancer risk
Food and Drug Administration (FDA) the semaglutide pill (Wegovy) and orforglipron (Foundayo) some people are considering making the switch from injectables
Extending your current lower dose for an extra two to four weeks can give your digestive system more time to adapt
Headache or dizziness: You can treat a headache with acetaminophen (Tylenol) without upsetting your G.I